United States Drugs for Vancomycin-Resistant Enterococcus Faecium Market Report 2016

November 2016 | 116 pages | ID: U4C92E7DCA4EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Drugs for Vancomycin-Resistant Enterococcus Faecium

Revenue, means the sales value of Drugs for Vancomycin-Resistant Enterococcus Faecium

This report studies sales (consumption) of Drugs for Vancomycin-Resistant Enterococcus Faecium in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Alchemia Limited
• Alvogen
• Aphios Corporation
• Cellceutix Corporation
• Enanta Pharmaceuticals
• Helix BioMedix
• LegoChem Biosciences
• Lytix Biopharma
• MGB Biopharma Limited
• Microbiotix

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Daptomycin
• Linezolid
• Quinupristin/dalfopristin
• Ampicillin
• Chloramphenicol
• Others

Split by applications, this report focuses on sales, market share and growth rate of Drugs for Vancomycin-Resistant Enterococcus Faecium in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Drugs for Vancomycin-Resistant Enterococcus Faecium Market Report 2016

1 DRUGS FOR VANCOMYCIN-RESISTANT ENTEROCOCCUS FAECIUM OVERVIEW

1.1 Product Overview and Scope of Drugs for Vancomycin-Resistant Enterococcus Faecium
1.2 Classification of Drugs for Vancomycin-Resistant Enterococcus Faecium
  1.2.1 Daptomycin
  1.2.2 Linezolid
  1.2.3 Quinupristin/dalfopristin
  1.2.4 Ampicillin
  1.2.5 Chloramphenicol
  1.2.6 Others
1.3 Application of Drugs for Vancomycin-Resistant Enterococcus Faecium
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Drugs for Vancomycin-Resistant Enterococcus Faecium (2011-2021)
  1.4.1 United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Growth Rate (2011-2021)
  1.4.2 United States Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue and Growth Rate (2011-2021)

2 UNITED STATES DRUGS FOR VANCOMYCIN-RESISTANT ENTEROCOCCUS FAECIUM COMPETITION BY MANUFACTURERS

2.1 United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Drugs for Vancomycin-Resistant Enterococcus Faecium Average Price by Manufactures (2015 and 2016)
2.4 Drugs for Vancomycin-Resistant Enterococcus Faecium Market Competitive Situation and Trends
  2.4.1 Drugs for Vancomycin-Resistant Enterococcus Faecium Market Concentration Rate
  2.4.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES DRUGS FOR VANCOMYCIN-RESISTANT ENTEROCOCCUS FAECIUM SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Market Share by Type (2011-2016)
3.2 United States Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue and Market Share by Type (2011-2016)
3.3 United States Drugs for Vancomycin-Resistant Enterococcus Faecium Price by Type (2011-2016)
3.4 United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Growth Rate by Type (2011-2016)

4 UNITED STATES DRUGS FOR VANCOMYCIN-RESISTANT ENTEROCOCCUS FAECIUM SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Market Share by Application (2011-2016)
4.2 United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES DRUGS FOR VANCOMYCIN-RESISTANT ENTEROCOCCUS FAECIUM MANUFACTURERS PROFILES/ANALYSIS

5.1 Alchemia Limited
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Alchemia Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Alvogen
  5.2.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Alvogen Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Aphios Corporation
  5.3.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Aphios Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Cellceutix Corporation
  5.4.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Cellceutix Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Enanta Pharmaceuticals
  5.5.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Enanta Pharmaceuticals Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Helix BioMedix
  5.6.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Helix BioMedix Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 LegoChem Biosciences
  5.7.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 LegoChem Biosciences Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Lytix Biopharma
  5.8.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Lytix Biopharma Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 MGB Biopharma Limited
  5.9.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 MGB Biopharma Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Microbiotix
  5.10.2 Drugs for Vancomycin-Resistant Enterococcus Faecium Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Microbiotix Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview

6 DRUGS FOR VANCOMYCIN-RESISTANT ENTEROCOCCUS FAECIUM MANUFACTURING COST ANALYSIS

6.1 Drugs for Vancomycin-Resistant Enterococcus Faecium Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Drugs for Vancomycin-Resistant Enterococcus Faecium

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Drugs for Vancomycin-Resistant Enterococcus Faecium Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Drugs for Vancomycin-Resistant Enterococcus Faecium Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES DRUGS FOR VANCOMYCIN-RESISTANT ENTEROCOCCUS FAECIUM MARKET FORECAST (2016-2021)

10.1 United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Revenue Forecast (2016-2021)
10.2 United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Forecast by Type (2016-2021)
10.3 United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Forecast by Application (2016-2021)
10.4 Drugs for Vancomycin-Resistant Enterococcus Faecium Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Drugs for Vancomycin-Resistant Enterococcus Faecium
Table Classification of Drugs for Vancomycin-Resistant Enterococcus Faecium
Figure United States Sales Market Share of Drugs for Vancomycin-Resistant Enterococcus Faecium by Type in 2015
Figure Daptomycin Picture
Figure Linezolid Picture
Figure Quinupristin/dalfopristin Picture
Figure Ampicillin Picture
Figure Chloramphenicol Picture
Figure Others Picture
Table Application of Drugs for Vancomycin-Resistant Enterococcus Faecium
Figure United States Sales Market Share of Drugs for Vancomycin-Resistant Enterococcus Faecium by Application in 2015
Figure United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales and Growth Rate (2011-2021)
Figure United States Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue and Growth Rate (2011-2021)
Table United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales of Key Manufacturers (2015 and 2016)
Table United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Share by Manufacturers
Figure 2016 Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Share by Manufacturers
Table United States Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue by Manufacturers (2015 and 2016)
Table United States Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Share by Manufacturers
Table 2016 United States Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Share by Manufacturers
Table United States Market Drugs for Vancomycin-Resistant Enterococcus Faecium Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Drugs for Vancomycin-Resistant Enterococcus Faecium Average Price of Key Manufacturers in 2015
Figure Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share of Top 3 Manufacturers
Figure Drugs for Vancomycin-Resistant Enterococcus Faecium Market Share of Top 5 Manufacturers
Table United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales by Type (2011-2016)
Table United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Share by Type (2011-2016)
Figure United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share by Type in 2015
Table United States Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue and Market Share by Type (2011-2016)
Table United States Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Drugs for Vancomycin-Resistant Enterococcus Faecium by Type (2011-2016)
Table United States Drugs for Vancomycin-Resistant Enterococcus Faecium Price by Type (2011-2016)
Figure United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Growth Rate by Type (2011-2016)
Table United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales by Application (2011-2016)
Table United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share by Application (2011-2016)
Figure United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share by Application in 2015
Table United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Growth Rate by Application (2011-2016)
Figure United States Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Growth Rate by Application (2011-2016)
Table Alchemia Limited Basic Information List
Table Alchemia Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Alchemia Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share (2011-2016)
Table Alvogen Basic Information List
Table Alvogen Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Revenue, Price and Gross Margin (2011-2016)
Table Alvogen Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share (2011-2016)
Table Aphios Corporation Basic Information List
Table Aphios Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Revenue, Price and Gross Margin (2011-2016)
Table Aphios Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share (2011-2016)
Table Cellceutix Corporation Basic Information List
Table Cellceutix Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Revenue, Price and Gross Margin (2011-2016)
Table Cellceutix Corporation Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share (2011-2016)
Table Enanta Pharmaceuticals Basic Information List
Table Enanta Pharmaceuticals Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Revenue, Price and Gross Margin (2011-2016)
Table Enanta Pharmaceuticals Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share (2011-2016)
Table Helix BioMedix Basic Information List
Table Helix BioMedix Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Revenue, Price and Gross Margin (2011-2016)
Table Helix BioMedix Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share (2011-2016)
Table LegoChem Biosciences Basic Information List
Table LegoChem Biosciences Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Revenue, Price and Gross Margin (2011-2016)
Table LegoChem Biosciences Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share (2011-2016)
Table Lytix Biopharma Basic Information List
Table Lytix Biopharma Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Revenue, Price and Gross Margin (2011-2016)
Table Lytix Biopharma Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share (2011-2016)
Table MGB Biopharma Limited Basic Information List
Table MGB Biopharma Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Revenue, Price and Gross Margin (2011-2016)
Table MGB Biopharma Limited Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share (2011-2016)
Table Microbiotix Basic Information List
Table Microbiotix Drugs for Vancomycin-Resistant Enterococcus Faecium Sales, Revenue, Price and Gross Margin (2011-2016)
Table Microbiotix Drugs for Vancomycin-Resistant Enterococcus Faecium Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Drugs for Vancomycin-Resistant Enterococcus Faecium
Figure Manufacturing Process Analysis of Drugs for Vancomycin-Resistant Enterococcus Faecium
Figure Drugs for Vancomycin-Resistant Enterococcus Faecium Industrial Chain Analysis
Table Raw Materials Sources of Drugs for Vancomycin-Resistant Enterococcus Faecium Major Manufacturers in 2015
Table Major Buyers of Drugs for Vancomycin-Resistant Enterococcus Faecium
Table Distributors/Traders List
Figure United States Drugs for Vancomycin-Resistant Enterococcus Faecium Production and Growth Rate Forecast (2016-2021)
Figure United States Drugs for Vancomycin-Resistant Enterococcus Faecium Revenue and Growth Rate Forecast (2016-2021)
Table United States Drugs for Vancomycin-Resistant Enterococcus Faecium Production Forecast by Type (2016-2021)
Table United States Drugs for Vancomycin-Resistant Enterococcus Faecium Consumption Forecast by Application (2016-2021)